Soleno’s drug misses key goal in Prader-Willi trial
The study failed to meet statistical significance for the primary endpoint, however, it did show a number of other significant benefits
Read More
Tag: DCCR
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
